Sponsor: 
Sanofi-Aventis Australia
Administration route: 
Intramuscular injection
Vaccine group: 
Adults aged ≥60 years only

Registered for use in people aged ≥60 years.

Quadrivalent inactivated influenza vaccine, split virion.

Each 0.7 mL monodose pre-filled syringe contains:

  • 60 µg haemagglutinin of each of the 4 recommended influenza virus strains
  • sodium chloride
  • dibasic sodium phosphate
  • monobasic sodium phosphate
  • octoxinol-9
  • water

May contain traces of:

  • ≤ 140 µg formaldehyde
  • ≤ 1 µg ovalbumin

For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.

Page history

Last updated: 
21 April 2022
Last reviewed: 
21 April 2022